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Problem Identification
•
•

Prostate cancer accounts for 26% of new cancer cases in US men.1

•
•

For men 70 and older the USPSTF recommends against PSA based screening (Grade D). 2

Current guidelines established by the U.S. Preventative Services Task Force (USPSTF) for
men age 55 to 69 years old state that the decision to be screened for prostate cancer
should be an individual one (Grade C). 2
Evidence that patient decision aids can improve patient knowledge, and reduce decisional
conflict. 3

•

These findings are weak, can a different modality of information representation aid in improving this
information exchange?

Public Health Cost
•
•
•
•

Estimated 3 year cost to Medicare associated with annual detection of prostate cancer in
men 70 or older is $1.2 billion.4
Typical cost of therapy to prostate cancer patient after diagnosis is about $2,800 per
month. 5
In Clinton County: 6

•
•

Average Annual Cases = 49.6; Rate per 100k = 92.0
Average Annual Deaths = 7.8; Rate Per 100k = 17.5

Nationally:

•

Rate of 111.3 per 100,000 men per year. The death rate was 19.0 per 100,000 men7

Clinician Perspectives
•
•

Perspectives obtained from Drs. ___, ___ and ___ of CVPH Family medicine.
All endorsed the importance of explaining risks and benefits of any screening test to patients but
acknowledged that these statistics can be abstract and hard for patients into interpret meaningfully.

•
•

•

Dr. ___ suggested that a graphical aid may be helpful in increasing patient comprehension of risks and benefits.
Dr. ___ agreed that a graphical representation would be not only beneficial for patient’s but also providers and something he
would like to incorporate into his practice.

Currently none of these providers use a decision making aid, graphical or otherwise in their conversations
about PSA screening.

Intervention
•
•
•

Patient decision making aids can improve patient’s knowledge and participation in decision
making and increase patient confidence in their decisions. 8
The goal is to incorporate a graphic patient decision making aid to help patients and
providers grasp the statistics in a more concrete way when engaging in shared decision
making around prostate cancer screening.
Implementation: Graphic can be printed out and brought into patient visits in which PSA
screening is expected to be discussed.

•

Alternatively could be incorporated as a dot phrase which can be drawn up and displayed during
patient encounters and included in AVS for patient’s reference.

Results
•

USPSTF produces a graphical decision-making aid based on their 2018 PSA
screening guidelines.

•

Received positive feedback from clinic providers and staff as to its ease of use and
potential benefit.

•

Graphic can be printed out and brought into patient visits in which PSA screening is
expected to be discussed.

Evaluation of Effectiveness and Limitations
•

Decision about screening is ultimately the patient decision, our role is to help
maximize their understanding of the risks and benefits. Thus effectiveness would
be best measured as improvement in patient comprehension.

•

•

A simple Likert scale styled questionnaire could be provided after visit to assess usefulness
of graphic in comprehension.

Limitations include language and literacy barriers, vision problems impairing ability
to interpret graphic.

Recommendations for the Future
• Future projects could examine the utility of this graphic both for the patient
and provider and identify + implement changes that might prove to be
beneficial.

• Ensure that data contained within the graphic is up to date with current
research.

References
1 - Siegel, RL, Miller, KD, Fuchs, H, Jemal, A. Cancer Statistics, 2021. CA Cancer J Clin. 2021: 71: 733. https://doi.org/10.3322/caac.21654
2 - https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancerscreening
3 - Riikonen JM, Guyatt GH, Kilpeläinen TP, Craigie S, Agarwal A, Agoritsas T, Couban R, Dahm P,
Järvinen P, Montori V, Power N, Richard PO, Rutanen J, Santti H, Tailly T, Violette PD, Zhou Q,
Tikkinen KAO. Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Metaanalysis. JAMA Intern Med. 2019 Aug 1;179(8):1072-1082. doi: 10.1001/jamainternmed.2019.0763.
PMID: 31233091; PMCID: PMC6593633.
4 - Trogdon JG, Falchook AD, Basak R, Carpenter WR, Chen RC. Total Medicare Costs Associated
With Diagnosis and Treatment of Prostate Cancer in Elderly Men. JAMA Oncol. 2019;5(1):60–66.
doi:10.1001/jamaoncol.2018.3701
5 – Zaorsky, Nicholas George, et al. “The Cost of Prostate Cancer Care to Society and to Patients in
the United States.” Journal of Clinical Oncology, vol. 37, no. 7_suppl, 2019, p. 116.
6 - New York State Cancer Registry. Cancer Incidence and Mortality in New York State, 1976-2018.
http://www.health.ny.gov/statistics/cancer/registry/. Accessed Date.
7 - https://seer.cancer.gov/statfacts/html/prost.html
8 - R Hoffman. (2018). Screening for Prostate Cancer. UpToDate. Retrieved August 8, 2021, from
https://www.uptodate.com/contents/screening-for-prostate-cancer

Consent Form
Thank you for agreeing to be interviewed. This project is a requirement for the Family Medicine clerkship. It will be stored on the Dana Library ScholarWorks website. Your
name will be attached to your interview and you may be cited directly or indirectly in subsequent unpublished or published work. The interviewer affirms that he/she has
explained the nature and purpose of this project. The interviewee affirms that he/she has consented to this interview.
Yes _____ /
Name: _Dr. _____________________________________________________________
Name: _Dr. _____________________________________________________________
Name: _Dr. _____________________________________________________________
No _____ /
Name: ______________________________________________________________
Name: ______________________________________________________________

